A role for FADD in T cell activation and development

Immunity

Volumn 8, Issue 4, 1998, Pages 439-449

  Walsh, Craig M ^a   Wen, Ben G ^a   Chinnaiyan, Arul M ^b   O'Rourke, Karen ^b,c   Dixit, Vishva M ^b,c   Hedrick, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; FAS ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LYMPHOCYTE DIFFERENTIATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

EID: 0032055344     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80549-X     Document Type: Article

References (80)

1. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., and Nagata, S. (1995). Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet. 11, 294-300.
2. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N., and Nagata, S. (1996). Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93, 2131-2136.
3. Allen, R.D., Marshall, J.D., Roths, J.B., and Sidman, C.L. (1990). Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 172, 1367-1375.
4. Amakawa, R., Hakem, A., Kundig, T.M., Matsuyama, T., Simard, J.J., Timms, E., Wakeham, A., Mittruecker, H.W., Griesser, H., Takimoto, H., et al. (1996). Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84, 551-562.
5. Anderson, S.J., Abraham, K.M., Nakayama, T., Singer, A., and Perimutter, R.M. (1992). Inhibition of T-cell receptor beta-chain gene rearrangement by overexpression of the non-receptor protein tyrosine kinase p56lck. EMBO J. 11, 4877-4886.
6. Baker, S.J., and Reddy, E.P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9.
7. Bodmer, J.L., Burns, K., Schneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schroter, M., Becker, K., et al. (1997). TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 6, 79-88.
8. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
9. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
10. Castedo, M., Macho, A., Zamzami, N., Hirsch, T., Marchetti, P., Uriel, J., and Kroemer, G. (1995). Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25, 3277-3284.
11. Castro, J.E., Listman, J.A., Jacobson, B.A., Wang, Y., Lopez, P.A., Ju, J.S., Finn, P.W., and Perkins, D.L. (1996). Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5, 617-627.
12. Chaffin, K.E., Beals, C.R., Wilkie, T.M., Forbush, K.A., Simon, M.I., and Perlmutter, R.M. (1990). Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9, 3821-3829.
13. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
14. Chinnaiyan, A.M., Tepper, C.G., Seldin, M.F., O'Rourke, K., Kischkel, F.C., Hellbardt, S., Krammer, P.H., Peter, M.E., and Dixit, V.M. (1996). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965.
15. Darnay, B.G., and Aggarwal, B.B. (1997). Early events in TNF signaling: a story of associations and dissociations. J. Leukoc. Biol. 61, 559-566.
16. Enari, M., Hug, H., and Nagata, S. (1995). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
17. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E.S. (1995). Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res. 55, 2737-2742.
18. Foy, T.M., Page, D.M., Waldschmidt, T.J., Schoneveld, A., Laman, J.D., Masters, S.R., Tygrett, L., Ledbetter, J.A., Aruffo, A., Claassen, E., et al. (1995). An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182, 1377-1388.
19. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
20. Godfrey, D. I., and Zlotnik, A. (1993). Control points in early T-cell development. Immunol. Today 14, 547-553.
21. - thymocyte differentiation. J. Immunol. 152, 4783-4792.
22. Griffith, T. S., Brunner, T., Fletcher, S.M., Green, D.R., and Ferguson, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
23. Griffith, T.S., Yu, X., Herndon, J.M., Green, D.R., and Ferguson, T.A. (1996). CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5, 7-16.
24. Groettrup, M., and von Boehmer, H. (1993). A role for a pre-T-cell receptor in T-cell development. Immunol. Today 14, 610-614.
25. Gross, J.A., Callas, E., and Allison, J.P. (1992). Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149, 380-388.
26. Herron, L.R., Eisenberg, R.A., Roper, E., Kakkanaiah, V.N., Cohen, P.L., and Kotzin, B.L. (1993). Selection of the T cell receptor repertoire in Lpr mice. J. Immunol. 151, 3450-3459.
27. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
28. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P. (1994). Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
29. Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P.M., and Peter, M.E. (1995). Cytotoxicity-dependent APO-1 Fas/CD95-associated proteinsform adeath-inducing signaling complex DISC with the receptor. EMBO J. 14, 5579-5588.
30. Kishimoto, H., and Sprent, J. (1997). Negative selection in the thymus includes semimature T cells. J. Exp. Med. 185, 263-271.
31. Kisielow, P., and von Boehmer, H. (1995). Development and selection of T cells: facts and puzzles. Adv. Immunol. 58, 87-209.
32. + thymocytes. Nature 333, 742-746.
33. Kitson, J., Raven, T., Jiang, Y.P., Goeddel, D.V., Giles, K.M., Pun, K.T., Grinham, C.J., Brown, R., and Farrow, S.N. (1996). A death-domain-containing receptor that mediates apoptosis. Nature 384, 372-375.
34. Kojima, H., Shinohara, N., Hanaoka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., et al. (1994). Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1, 357-364.
35. Komiyama, T., Ray, C.A., Pickup, D.J., Howard, A.D., Thornberry, N.A., Peterson, E.P., and Salvesen, G. (1994). Inhibition of interleukin-1beta converting enzyme by the cowpox virus serpin CrmA: an example of cross-class inhibition. J. Biol. Chem. 269, 19331-19337.
36. - T cells of lpr mice. J. Exp. Med. 168, 2221-2229.
37. Lazebnik, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G., and Earnshaw, W.C. (1994). Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
38. Levin, S.D., Anderson, S.J., Forbush, K.A., and Perlmutter, R.M. (1993). A dominant-negative transgene defines a role for p56lck in thymopoiesis. EMBO J. 12, 1671-1680.
39. Lowin, B., Hahne, M., Mattmann, C., and Tschopp, J. (1994). Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652.
40. Lynch, D.H., Watson, M.L., Alderson, M.R., Baum, P.R., Miller, R.E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C.A., Hunter, K., and et al (1994). The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131-136.
41. -/- mice. Cell 89, 1011-1019.
42. Martins, L.M., Kottke, T., Mesner, P.W., Basi, G.S., Sinha, S., Frigon, N.J., Tatar, E., Tung, J.S., Bryant, K., Takahashi, A., et al. (1997). Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem. 272, 7421-7430.
43. Matsumoto, M., Mariathasan, S., Nahm, M.H., Baranyay, F., Peschon, J.J., and Chaplin, D.D. (1996). Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271, 1289-1291.
44. Matsuzawa, A., Moriyama, T., Kaneko, T., Tanaka, M., Kimura, M., Ikeda, H., and Katagiri, T. (1990). Anew allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 171, 519-531.
45. Matsuzawa, A., Kimura, M., Muraiso, T., Kominami, R., and Katagiri, T. (1991). Genotype-restricted lymphoproliferation in autoimmune lpr mice. Eur. J. Immunol. 21, 1535-1542.
46. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 05, 817-827.
47. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
48. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
49. Page, D.M., Roberts, E.M., Peschon, J.J., and Hedrick, S.M. (1998). TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160, 120-133.
50. Pan, G., O'Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J., and Dixit, V.M. (1997). The receptor for the cytotoxic ligand TRAIL. Science 276, 111-113.
51. +) thymocytes in normal and genetically modified mice. J. Immunol. 154, 5103-5113.
52. Pennington, M.W., and Thornberry, N.A. (1994). Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer. Peptide Res. 7, 72-76.
53. Petit, P.X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M.L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130, 157-167.
54. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179, 709-713.
55. - thymocytes are functionally immature. J. Immunol. 147, 1779-1785.
56. Rathmell, J.C., Townsend, S.E., Xu, J.C., Flavell, R.A., and Goodnow, C.C. (1996). Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87, 319-329.
57. Ray, C.A., Black, R.A., Kronheim, S.R., Greenstreet, T.A., Sleath, P.R., Salvesen, G.S., and Pickup, D.J. (1992). Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme. Cell 69, 597-604.
58. Rouvier, E., Luciani, M.F., and Golstein, P. (1993). Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200.
59. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O., and Korsmeyer, S.J. (1991). bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888.
60. Shi, Y.F., Bissonnette, R.P., Parfrey, N., Szalay, M., Kubo, R.T., and Green, D.R. (1991). In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol. 146, 3340-3346.
61. -. J. Immunol. 144, 3756-3761.
62. Singer, G.G., and Abbas, A.K. (1994). The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371.
63. Smith, K.G., Strasser, A., and Vaux, D.L. (1996). CrmA expression in T lymphocytes of transgenic mice inhibits CD95 Fas/APO-1-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176.
64. Surh, C.D., and Sprent, J. (1994). T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372, 100-103.
65. Swan, K.A., Alberola-lla, J., Gross, J.A., Appleby, M.W., Forbush, K.A., Thomas, J.F., and Perlmutter, R.M. (1995). Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14, 276-285.
66. Sytwu, H.K., Liblau, R.S., and McDevitt, H.O. (1996). The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5, 17-30.
67. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
68. Tewari, M., and Dixit, V.M. (1995). Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260.
69. Tewari, M., and Dixit, V.M. (1996). Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6, 39-44.
70. Varfolomeev, E.E., Boldin, M.P., Goncharov, T.M., and Wallach, D. (1996). A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1 : proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183, 1271-1275.
71. Vincenz, C., and Dixit, V.M. (1997). Fas-associated death domain protein interleukin-1 beta-converting enzyme 2 (FLICE2), an ICE/ Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J. Biol. Chem. 272, 6578-6583.
72. Wadsworth, S., Yui, K., Siegel, R.M., Tenenholz, D.E., Hirsch, J.A., and Greene, M.I. (1990). Origin and selection of peripheral CD4-CD8-T cells bearing alpha/beta T cell antigen receptors in autoimmune gld mice. Eur. J. Immunol. 20, 723-730.
73. Walsh, C.M., Glass, A.A., Chiu, V., and Clark, W.R. (1994a). The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J. Immunol. 153, 2506-2514.
74. Walsh, C.M., Matloubian, M., Liu, C.C., Ueda, R., Kurahara, C.G., Christensen, J.L., Huang, M.T., Young, J.D., Ahmed, R., and Clark, W.R. (1994b). Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91, 10854-10858.
75. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
76. Yuan, J. (1997). Transducing signals of life and death. Curr. Opin. Cell Biol. 9, 247-251.
77. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J.L., Petit, P.X., and Kroemer, G. (1995a). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181, 1661-1672.
78. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S.A., Petit, P.X., Mignotte, B., and Kroemer, G. (1995b). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
79. Zhang, J., and Winoto, A. (1996). A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol. Cell. Biol. 16, 2756-2763.
80. Zhou, T., Bluethmann, H., Eldridge, J., Brockhaus, M., Berry, K., and Mountz, J.D. (1991). Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J. Immunol. 147, 466-474.